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Evidence has been previously presented to show that lathyrogenic agents 
increase the solubility of collagen and the fragility of the  connective tissues 
in the chick embryo (1). Assay systems for the detection of lathyrogenic agents 
have hitherto relied upon loss of weight and morphological changes in the rat 
as criteria of activity. In the chick embryo however, skeletal deformity can 
occur in the absence of changes in collagen solubility, and vice versa  (1). Since 
the  changes  in  the  functional properties  of collagen  were  considered  to  be 
more fundamental  than  changes  in  morphology, an  assay  system has  been 
used  based  on  collagen  solubility and  tissue  tensile  properties  in  the  chick 
embryo (2). 
The main interest in lathyrism stems from its usefulness as a tool with which 
to study mechanisms by which collagen, once laid down,  may be mobilized, 
but  so far studies  on  the lathyrogenic nitriles,  such  as  fl-aminopropionitrile 
(BAPN), have failed to elucidate such mechanisms.  During an investigation 
into the nature of chemical groups possessing lathyrogenic activity using the 
chick embryo assay  method,  it  was  repeatedly noted  that  isonicotinic  acid 
hydrazide ("isoniazid" or INAH)  a  compound effective against  tuberculosis, 
possessed  marked  lathyrogenic  activity.  This  report  discusses  its  mode  of 
action, comparing it with that of BAPN, the reversal of the INAH effect by 
pyridoxal, and the possible relevance of these findings to mechanisms of col- 
lagen mobilization. 
Materials and Methods 
Fertile eggs of the White Leghorn variety were injected v/a the chorio-allantoic  membrane 
with isonicotinic  acid hydrazide (INAH)I or ~-aminopropionitrile  (BAPN)  2 in distilled water 
* This study was aided by a grant from Muscular Dystrophy Associations of America, 
Inc. 
Research Fellow of the Helen Hay Whitney Foundation. 
1  Kindly supplied by Dr. H. L. Morrison of Roche Products, Welwyn Garden City, Eng- 
land. 
2 Kindly supplied by Abbott Laboratories of North Chicago. 
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through a  pinhole drilled into the shell,  the hole being then covered with Scotch tape and 
the egg reincubated at 37°C.  The bulk of the experiments on collagen solubility were per- 
formed on 14 day embryos and the survivors harvested 2 days later at 16 days. An absolute 
minimum of 15  embryos was injected for each experiment, the usual  dose being 0.054  m~ 
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TExT-FIG. 1.  Dosage effcct of INAH on relative viscosity and hydroxyproline content of 
1 ~  sodium chloride extracts of bones from 16 day embryos treated 2 days earlier. 
per egg dissolved in 0.1 ml. sterile distilled water. Comparisons between the effects of different 
compounds were always on an equimolar basis. 
Fragility Measurements.--Changes in  the  tensile properties of  the whole embryo were 
determined as previously described (2) by measuring the average time necessary for a constant 
stretching load to separate the head from the body of 15 to 20 embryos aged 16 days, which 
had been injected 2 days earlier with 0.054 m~ of the compound being tested. The "fragility 
index" used was: 
Average time for separation, in seconds 
Average embryo weight in grams 
Comparison of fragility indices was made on eggs of the same batch only, using the same 
stretching load. C.  I.  LEVENE  797 
Extraction Procedure.--As  previously described (1)  tibiae and femora from a  minimum o[ 
9 embryos aged 16 days which had been injected 2 days earlier, were carefully dissected on 
ice, pooled, minced with fine scissors, and extracted with 2 volumes of cold 1 ~s sodium chloride 
buffered with phosphate,  pH 7.6, ionic strength 0.02,  at 5°C., with constant shaking for 24 
hours. The extract was separated from the residue by centrifugation in the Spinco model L 
preparatory ultracentrifuge at 20,000 R.P.~. for 30 minutes and the supernatant passed through 
a sintered glass filter in the cold. 
The relative viscosity of each extract, which gave an index of the amount of collagen in 
solution  (3)  was measured  in an Ostwald  viscometer at 5°C.  Occasionally as a  check,  the 
hydroxyproline content of the extract was measured since hydroxyproline in the bound form, 
forms approximately 14 per cent of the dry weight of collagen to which protein it is virtually 
peculiar. 
TABLE  I 
Table Showing Residual Collagen after Extraction of Bones of 16 Day Embryos 
Treated Z Days Earlier witk Various Doses of [NAH 
INAH dose  n rel of bone extracts  Hydroxyprollne  content of 
bone residues 
reg.~egg 
0 
3.7 
7.4 
14.8 
1.9 
11.9 
21.2 
24.5 
per cent dry ~eight 
1.97 
1.78 
1.43 
1.93 
Analytical Method.--Extracts and residues were analyzed for hydroxyproline content after 
hydrolysis in sealed tubes at 138°C.  for 3 hours in an oil bath,  using a  modification of the 
method of Neuman and Logan (4)  with a  blank omitting peroxide to account for possible 
interference from other pyrroles (5). 
All the data presented are derived from a  minimum of 15 embryos in order to minimize 
individual differences. 
Skdetal Deforraities.--In  order to show that a compound is capable of producing skeletal 
deformities in the chick embryo it is necessary to inject the compound at 4 days of incubation 
instead of at 14 days. A minimum of 15 fertile embryos was therefore injected with the most 
suitable dose, 0.00253 m~s, through a pinhole in the shell and the survivors at 14 days cleared 
and stained with alizarin in order to clearly demonstrate the skeleton (6). 
Synthesis  of Hydrazones of INAH.--Pyridoxal hydrazone of INAH was prepared  by the 
mixture of solutions of pyridoxal hydrochloride, INAH, and sodium acetate and the resulting 
precipitate  twice recrystallized  from  ethanol  (m.p.  250°C.).  The  benzaldehyde  and  sali- 
cylaldehyde hydrazones of INAH were prepared  by the addition of ethanolic solutions of 
the aldehydes to aqueous INAH and the resulting precipitates washed with water and ethanol 
(benzaldehyde hydrazone m.p. 193°C., salicylaldehyde hydrazone m.p. 248°C.).  The strepto- 
mycin hydrazone of INAtt used  was "streptohydrazid ''3  (m.p. 230°C.).  The melting points 
of the above compounds were determined using the Kofler micro-melting point apparatus,  in 
order to establish identity with known compounds where possible,  as well as the absence of 
INAH (m.p. 171°C.) and of pyridoxal (m.p. 165°C.). 
a Streptohydrazid kindly supplied by the Pfizer Corporation, Harwich, England. 798  ISONICOTINIC  ACID  HYDF, AZIDE 
EXPE  RIMENTAL 
INAtt  Effect.--Increase  in  the  dosage  of INAH resulted  in  increased  ex- 
tractibility  of collagen,  as measured  by  the  relative  viscosity  and  hydroxy- 
proline content  of the  extracts  (Text-fig.  1),  reaching a  maximum at  7.4 rag. 
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TExT-FIG. 2. Effect of 7.4 rag.  of INAH injected at 14 days on subsequent  fragility of 
embryo and extractability  of collagen. Fragility Index used here was: 
Load required to rupture control embryos 
Load required to rupture treated  embryos 
within 20 seconds. 
of INAH  (0.054  m~).  With  the  exception  of the  normal  extracts,  all  these 
extracts gelled at 37°C.,  going back into solution on subsequent  cooling, thus 
behaving in this respect like normal collagen (7, 8)  and like the extracts from 
BAPN-treated embryos. 
Analyses of the  collagen content  of the  residues  after  extraction  (Table  I) 
indicated  that  the  failure  of the  higher  doses  of INAH to yield  further  ex- 
tractable collagen was not due to its absence from the bones. C.  I.  LEVENE  799 
The effect of a  single dose of 7.4 mg. of INAH as measured by the extract 
viscosity reached a  peak  2  days  after injection, slowly subsiding  to almost 
normal  at  hatching  time;  changes  in  embryo  fragility  followed  a  parallel 
course although with a slight lag in time (Text-fig. 2). 
Reversal of INAtt Effect with Pyridoxal.--The normal metabolism of vitamin 
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TExT-FIO. 3. Effect of time of injection of 11.0 rag. of pyridoxal on extractability of 
collagen from embryos treated with 7.4 mg. of INAH at 14 days. 
B6 in the higher animals  has been shown to be inhibited by INAH; it was 
evident that the injection of an equimolar amount of pyridoxal hydrochloride 
into  an  embryo previously  treated  with  INAH  diminished  the  amount  of 
collagen  extractable  from  the  bones,  irrespective  of  the  time  of  pyridoxal 
injection (Text-fig. 3). This reversal effect was more clearly demonstrated when 
INAH was injected at 14 days, pyridoxal at 15 days, and the bones harvested 
at  16  days,  since  the  final  extract viscosity, although  never quite  reaching 
normal, was much lower than that at the time of pyridoxal injection. Pyridoxal 
itself was found to be quite toxic to the embryo (Text-fig. 4) producing loss of 800  ISONICOTINIC  ACID  HYDRAZIDE 
weight and a  very slight diminution in the relative viscosity of bone extracts 
from that of the normal  (Table II). When given with INAH the toxicity of 
pyridoxal was diminished (Table III) and whereas it still caused loss of weight 
it nevertheless produced increase in the embryo tensile strength  with diminu- 
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TExT-FIG. 4.  Effect of pyridoxal dosage on mortality rate of 16 day embryos injected 2 
days earlier. 
TABLE II 
Effect of Pyridoxal on Weight and Rdative  Viscosity of Bone Extracts in 16 Day 
Embryos Treated 2 Days Earlier 
Pyridoxal dosage  Average embryo weight*  ,7 rel 
,ng./egg 
0 
0.70 
2.75 
11.0 
22.0 
gm. 
16.4 
16.8 
15.3 
15.1 
Died 
1.8 
1.9 
1.7 
1.5 
* A minimum of 15 eggs was used in each group. 
tion in the amount of extractable collagen (Table IV) resulting in functional 
improvement with respect at least, to collagen. 
Comparison  of INAH  Effect  with  That  of  BAPN.--Treatment  of  14  day 
embryos with various doses of BAPN resulted  in a  threefold increase in  the 
yield of extractable collagen as compared with the effect of an equimolar dose 
of 1NAH; the general shape of the curve however, was similar  (Text-fig. 5). C.  I.  LEVENE  801 
The  effect  of  0.054  n~  of  BAPN  on the  embryo fragility and collagen ex- 
tractability  was also similar to, though larger in magnitude than, that of 0.054 
m~ of INAH (Text-fig. 6). 
TABLE III 
Effect of Pyridoxal on Mortality Rate of 16 Day Embryos Treated 2 Days Earlier 
with INAH 
Experiment No.*  INAH dose  Mortality with INAH 
alone 
mg./egg 
3.7 
7.4 
7.4 
7.4 
7.4 
7.4 
7.4 
7.4 
14.8 
per ten/ 
11 
0 
0 
0 
10 
0 
10 
0 
11 
Mortality with INAH and 
11.0 rag. pyridoxal/egg 
~ber cen| 
45 
12 
30 
40 
10 
10 
10 
10 
11 
* A minimum of 15 eggs was used in each experiment. 
TABLE IV 
Effect of 11.0 Mg. of Pyridoxal on Embryos Treated with 7.4 Mg. of INAH at 14 
Days and Examined at 16 Days 
Experi- 
ment 
No.* 
Average embryo weight 
Control 
g~. 
17.3 
16.4 
16.4 
17.0 
17.4 
INAH 
gm. 
17.4 
16.8 
16.8 
17.1 
17.6 
INAH + 
pyridoxal 
16.0 
15.8 
15.2 
16.5 
16.5 
Fragility index 
(Time to produce rupture 
Average embryo weight) 
rel of bone extracts 
Control  Control  ~  ~+  pyfidoxal 
7.0  0.3  5.4 
7.0  0.4  3.0 
7.0  0.4  3.3 
8.O  O.3  5.2 
INAH 
13.1 
14.7 
14.7 
21.2 
16.4 
1.8 
1.8 
1.8 
1.9 
1.8 
INAH + 
pyridoxal 
3.6 
7.0 
5.4 
6.5 
5.0 
* A minimum of 60 eggs was used in each experiment. In Experiments  1, 2, pyridoxal 
was injected at the same time as INAH; in Nos. 3, 4, and 5, pyridoxal was injected 24 hours 
after INAH. 
Effect  of  Pyridoxal  on  BAPN-Treated  Embryo.--Unlike  INAH,  BAPN 
enhanced the toxicity of pyridoxal (Table V), and whilst the average embryo 
weight was lowered, just as with INAH, there was however, no improvement 
in either the tissue tensile strength or in the relative viscosity of bone extracts 
(Table VI). 802  ISONICOTINIC  ACID  HYDRAZIDE 
INAH-Pyridoxal  Relationship.--The  effect  of  varying  either  pyridoxal 
dosage (Text-fig. 7)  or that of INAH (Table VII) suggested that interaction 
between the two compounds was based on a quantitative relationship; further- 
more, injection of the two compounds either at two separate sites in the same 
egg, or at a  single site after prior mixing in vitro, gave similar results  (Table 
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TzxT-FIG.  5. Dosage effect of BAPN on relative viscosity  of 1 ~r sodium chloride extracts 
of bones from 16 day embryos treated 2 days earlier. 
viii).  Pyridoxine had  no  effect on  the  relative  viscosity  of  extracts  from 
INAH-treated embryos, suggesting that the aldehyde group of pyridoxal was 
essential for reversal to take place. In order to test this, other aldehydes were 
injected into INAH-treated embryos. It was  seen  (Text-fig. 8)  that  whereas 
streptomycin had  no  effect,  and  salicylaldehyde and  benzaldehyde  a  small 
effect, that of pyridoxal was the greatest; none of the aldehydes injected alone 
possessed lathyrogenic activity. Moreover, with the exception of streptomycin 
hydrazone of INAH, very little  lathyrogenic activity was  produced by  the 
pyridoxal and benzaldehyde hydrazones of INAH,  whilst  the salicylaldehyde C.  I.  LEVElqE  803 
hydrazone proved  to  be  too  toxic  a  compound.  These  results  suggested  a 
possible mode of action of pyridoxal,  by the formation of a Schiff's base with 
INAH; the fact that both pyridoxal and benzaldehyde could inactivate INAH 
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by  complexing with it  in  vitro, yet only pyridoxal effectively  reversed  the 
effect of INAH in viva, pointed to the relatively specific action of pyridoxal. 
Do Other Known Nicotinamide-Antagonists  Possess Lathyrogenic Activity?-- 
Since INAH has been shown in other systems to be an antinicotinamide agent 
(9, 10), the effect of 3-acetyl pyridine and 6-amino nicotinamide was tested to 
see whether they were lathyrogenic; they were inactive. 
Are the Degradation Products of INAH Lathyrogenic?--INAH is metabolized 804  ISONICOTINIC  ACID  IIYDRAZIDE 
in the human and excreted in the urine as isonicotinic and isonicotinuric  acids 
(11).  These  two  compounds  were  tested  for  lathyrogenic  activity but  were 
found to be inactive) 
Comparison  of Deformity-Producing  Effects  of INAH  and  BAPN.--When 
TABLE V 
Effect oJ Pyridoxal on Mortality Rate of 16 Day Embryos Treated 2 Days Earlier 
with BAPN 
Experiment No.*  BAPN dose  Mortality with BAPN  Mortality with BAPN and 
alone  11.0 mg. pyridoxal/egg 
reg.~egg 
2.5 
5.0 
5.0 
6.86 
6.86 
10.0 
10.0 
per ¢~I 
16 
16 
10 
10 
0 
33 
50 
p~¢enh 
100 
90 
64 
4O 
88 
100 
100 
* In Experiments 1, 2, 6, and 7, pyridoxal was injected at 14 days; in Experiments 3, 4 
and 5, at 15 days. 
A minimum of 15 eggs was used in each experiment. 
TABLE VI 
Effect of Pyridoxal (11.0 reg.~egg) on Embryos Treated with BAPN at 14 Days and 
Examined at 16 Days 
Experiment* 
5.0 mg. 
BAPN/egg 
5.86 mg. 
BAPN/egg 
A'¢erage embryo weight 
Control 
gm, 
18.3 
17.7 
BAPN 
g  f6. 
16.9 
17.6 
BAPN  + 
pyridoxal 
g~/L 
15.6 
15.9 
Fragility index 
(Time to produce rupture 
Average embryo weight) 
BAPN  + 
Control  BAPN  pyridoxal 
8.0  1.0  0.3 
8.0  1.6  1.6 
rel of bone extracts 
* A minimum of 60 eggs was used in each experiment. 
Control  BAPN 
2.0  33.0 
1.7  131.3 
i 
BAPN  + 
pyridoxa] 
30.5 
38.0 
0.00253  mM  of  BAPN  was  injected  into  4  day  embryos  and  the  survivors 
examined  6  days later, severe  tibial bowing  and  deformity of the  beak  was 
observed (1). Associated with the deformities there was a  slight, but  for  such 
an early embryo, significant increase in the relative viscosity of bone extracts, 
and  a  large  increase  in  the  embryo  fragility;  the  INAH-treated  embryos, 
4 The generous gift of Dr. D. Dearnaley, Biochemistry  Department, University of Oxford. P 
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TExT-FxG.  7.  Dosage effect of pyridoxal injected at 15 days, on extractability of collagen 
from embryos treated with 7.4 rag, of INAH at 14 days, 
TABLE VII 
Effect on Fragility  and Rdative Viscosity of Bone Extraxts in 16 Day Embryos  Treated 
2 Days Earlier with Varying Doses on INAH and 11.0 Mg. of PyrldoxaI 
Fragility Index*  ~1 tel 
INAH dosage 
INAH  INAH +  pyridoxal  INAH  INAH +  pyfidoxal 
reg.~egg 
0 
3.7 
7.4 
14.8 
8.0 
4.8 
0.3 
0.1 
7.0 
5.2 
0.8 
1.9 
11.9 
21.2 
24.5 
4.2 
6.5 
11.6 
* FragiUty index - 
Time for rupture 
Average embryo weight' using constant load of 140 gm. 
whilst showing no sign of beak or tibial deformity even at 12 times the dosage, 
(Fig.  1), nevertheless still showed increased relative viscosity of bone extracts 
and  embryo  fragility  (Table  IX),  suggesting  that  the  two  phenomena  are 
possibly dissociated. 806  ISONICOTINIC  ACID  HYDRAZIDE 
TABLE  VIII 
Comparison  of in Vivo and in Vitro Effects  of [NAH-Pyridoxal Admixture, in 16 
Day Embryos  Treated 2 Days Earlier 
rt rel of bone extracts 
INAH dosage  INAH and pyridoxal 11.0  INAH and pyridoxal 11.0 
INAIt alone  nag,: injectedat separate  rag.: injected  after 
sites in vivo  mixing in vitro 
reg.~egg 
0 
3.7 
7.4 
14.8 
1.9 
11.9 
21.2 
24.5 
4.2 
6.5 
11.6 
3.2 
5.0 
12.2 
.° I 
INAH  alone 
INAH + streptomycin 
15 
C 
I  // 
INAH +  benzaldehyde 
INAH + salicylaldehyde 
/0  iNAH -- streptomycin complex 
/ 
O INAH-pyridoxal complex 
OIINAH  -- benzaldehyde  complex 
INAH q- pyridoxal 
f  control  pyridoxal 
streptomycin 
benzaldehyde 
sal icylaldehyde 
14  15  16 
Embryo  age in days 
T•xT-FIO.  8.  Comparison of (a) the effects of various aldehydes on INAH-treated embryos 
and (b)  the effects of INAH with those of various aldehyde-INAH complexes. c.  i.  LV.VVNV,  807 
DISCUSSION 
Although both INAH and BAPN are lathyrogenic compounds, their modes 
of action  appear  to differ; BAPN produces  skeletal deformities, but  INAH 
does not; BAPN  treatment  results in  a  large  amount  of collagen becoming 
soluble, whereas INAH  releases much less,  and whilst pyridoxal has no effect 
on the former, it reverses the latter. 
TABLE IX 
Comparison of Effects of BAPN and INAH-Treated Embryos Injected at 4 Days 
with 0.00253 m~ and Examined  at 10 Days 
Dosage* 
mg. 
0 
BAPN 
0.32 mg. 
INAH 
0.25 mg. 
INAH 
0.80 mg. 
INAH 
2.00 mg. 
INAH 
4.00 mg. 
Average weight of 
embryos 
gm, 
1.85 
2.00 
2.03 
2.20 
2.00 
1.83 
t  Fragility index 
(Time to produce  rupture 
Average embryo  weight 
with constant load of S gin.) 
40+ 
0.5 
40+ 
40+ 
32 
13 
rel of bone extracts 
1.9 
3.1 
2.3 
2,7 
2.9 
2.5 
* A minimum of 15 eggs was used in each experiment. 
In  considering firstly the  INAH  effect,  two  obvious possibilities  emerge; 
firstly INAH may act by combining to form a Schiff's base with the embryo's 
available pyridoxal and so produce a deficiency. There is fairly good evidence 
that pyridoxal will combine with specific groups of certain biologically active 
compounds whose activity is consequently lost; examples of this include the 
reversal in the rat of the toxic effect of l-penicillamine by pyridoxal with which 
it  combines chemically (12,  13),  the loss of biological activity of many acid 
hydrazides in the presence of vitamin B6 (14), and the reversal by pyridoxal 
of the in vitro inhibition of Mycobacterium tuberculosis induced by INAH (15). 
In the latter case, the aldehyde group was shown to be essential for reversal, 808  ISONICOTINIC  ACID  ttYDRAZIDE 
since  neither  pyridoxine  nor  pyridoxamine  were  effective.  A  second  more 
remote  possibility  is  that  INAH  may displace  the  nicotinamide  portion  of 
diphosphopyridine nucleotide  (DPN)  as demonstrated in  another system by 
Zatman and his colleagues (9) who isolated and characterized the DPN-INAH 
analogue (10). 
In considering the reversal of the INAH effect by pyridoxal, it  is  not yet 
apparent whether it acts simply by curing pyridoxal deficiency should it exist, 
or by combining with as yet unmetabolized INAH and so speeding the natural 
healing. 
The small amount of lathyrogenic activity of the pyrodoxal hydrazone of 
INAH may have been due to the small amount of INAH, which, it has been 
suggested, is released by the in vivo hydrolysis of the complex (16). 
No direct evidence has been presented here to show that the DPN system is 
involved; indeed, if it were, one might have expected antinicotinamide agents 
other than INAH to be lathyrogenic, but this was not found to be the case. 
However the indirect evidence appears sufficiently strong to warrant considera- 
tion  of  the  possibility  that  the  mobilization  of collagen  in  fibrillar  form  is 
mediated through an enzyme system, particularly since knowledge concerning 
collagen-mobilizing systems  is  scanty  (17). 
The author  wishes to  thank  Professor  Sir  Howard  Florey,  P.R.S.,  for  encouragement, 
Drs. E. P. Abraham, F.R.S.,  H. Blaschko, and G. G. F. Newton for helpful discussion, Miss 
Valerie Petts  for invaluable technical assistance, Miss Christine Court, and  Mr.  Stanley 
Buckingham for reproduction of graphs and photographs. 
SUMMARY 
When applied to the chorio-allantoic membrane of the chick embryo, isoni- 
azid was shown to produce an increase in the fragility of the embryo and in 
the amount of collagen which was extractable from the bones with cold 1 ~t 
sodium chloride. The administration  of pyridoxal reversed these phenomena 
almost completely. 
The effect of isoniazid differed from that of/5-aminopropionitrile in that the 
latter was of greater magnitude,  and was not affected by pyridoxal; whereas 
/~-aminopropionitrile caused skeletal deformities, isoniazid even at 12 times the 
concentration produced no deformities. 
The aldehyde group of pyridoxal was shown  to be necessary for its inter- 
action with isoniazid. 
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FIG. 1.  Effect on skeleton of 0.00253  mM injected at 4  days and examined at  14 
days. 
1  a.  BAPN-treated embryo showing bowed tibiae and deformed beak. 
1 b.  INAI-I-treated embryo showing absence of deformities. THE  JOURNAL  OF  EXPERI~{ENTAL  MEDICINE  VOL.  113  ~LATE  79 
(Levene: Isonicotinic acid hydrazide) 